ArticleCureus2026
Severe Arterial Thrombosis Revealing Underlying Nephrotic Syndrome.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A man in his 30s with hypertension presented with acute left lower limb pain and numbness for one week. Imaging revealed a thrombus at the left iliac bifurcation, following which he underwent urgent thromboembolectomy. Despite repeated interventions and anticoagulation, re-occlusion occurred the following day, ultimately requiring an above-knee amputation. Persistent hypoalbuminaemia and proteinuria prompted further evaluation, revealing nephrotic syndrome. Due to heparin resistance from severe hypoalbuminaemia, anticoagulation was switched from unfractionated heparin to argatroban. Immunosuppression with high-dose steroids and rituximab was initiated, chosen to cover potential causes including minimal change disease (MCD), membranous nephropathy (MN), and focal segmental glomerulosclerosis (FSGS). A renal biopsy could not be performed due to continuous anticoagulation. The second rituximab dose was delayed due to stump infection of the amputated limb. The patient's albumin and proteinuria improved significantly following the treatment. This case highlights the need for early urine protein testing in unexplained hypoalbuminaemia or arterial thrombosis, to investigate nephrotic syndrome as a potential cause. Prompt treatment is key to preserve kidney function and reduce the chance of limb loss.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.